Parallax Volatility Advisers’s Foundation Medicine, Inc. FMI Stock Holding History

Parallax Volatility Advisers’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-300,000	Closed	-$23.6M	–	3832
2018 Q1	$23.6M	Sell	300,000 -10,000	-3%	-$738K	0.03%	223
2017 Q4	$21.1M	Sell	310,000 -30,000	-9%	-$1.56M	0.03%	249
2017 Q3	$13.7M	Sell	340,000 -217,800	-39%	-$8.4M	0.02%	338
2017 Q2	$22.2M	Buy	557,800 +294,000	+111%	+$10.8M	0.04%	237
2017 Q1	$8.51M	Buy	+263,800	New	+$6.58M	0.02%	426
2015 Q1	–	Sell	-1,000	Closed	-$22K	–	6023
2014 Q4	$22K	Buy	+1,000	New	+$23.1K	﹤0.01%	4422

Other funds holding FMI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Parallax Volatility Advisers's FMI Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Foundation Medicine, Inc. (FMI) in Q1 2018, closing a stake of 2,226 shares — an estimated $164K sold.

Parallax Volatility Advisers first reported a position in FMI in Q3 2017 and held it in 2 quarters. The position peaked at $245K in Q3 2017. 144 funds tracked by Wall St. Rank hold FMI as of Q1 2018.

Parallax Volatility Advisers reported no remaining Foundation Medicine, Inc. position as of Q1 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 2,226 Foundation Medicine, Inc. shares in Q1 2018, an estimated $164K.
Parallax Volatility Advisers first reported a position in Foundation Medicine, Inc. in Q3 2017 and held it in 2 quarters.
Parallax Volatility Advisers's Foundation Medicine, Inc. position peaked at $245K in Q3 2017.
144 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.